Healthcare utilisation of 282,080 individuals with long COVID over two years: a multiple matched control, longitudinal cohort analysis
Journal of the Royal Society of Medicine · 2024
DOI: 10.1177/01410768241288345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Royal Society of Medicine, 2024. Verfasst von Yi Mu und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Health Informatics, University College London, London, UK. Hauptthemen laut MEDLINE: COVID-19, Patient Acceptance of Health Care. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHS England, British Heart Foundation, National Institute for Health and Care Research.
Abstract (Originalsprache)
Objectives
To investigate healthcare utilisation and cost in individuals with long COVID (LC) at population level.
Design
Case–control cohort analysis with multiple age-, sex-, ethnicity-, deprivation-, region- and comorbidity-matched control groups: (1) COVID only, no LC; (2) pre-pandemic; (3) contemporary non-COVID; and (4) pre-LC (self-controlled, pre-COVID pandemic).
Setting
National, population-based, linked UK electronic health records (British Heart Foundation/NHS England Secure Data Environment).
Participants
Adults aged ≥18 years with LC between January 2020 and January 2023. Main outcome measures Healthcare utilisation (number of consultations/visits per person: primary care (general practitioner [GP]), secondary care (outpatient [OP], inpatient [IP] and emergency department [ED], investigations and procedures) and inflation-adjusted cost (£) for LC and control populations per month, calendar year and pandemic year for each category.
Results
A total of 282,080 individuals with LC were included between January 2020 and January 2023. The control groups were COVID only, no LC ( n = 1,112,370), pre-pandemic ( n = 1,031,285), contemporary non-COVID ( n = 1,118,360) and pre-LC ( n = 282,080). Healthcare utilisation per person (per month/year) was higher in LC than controls across GP, OP and ED. For IP, LC had higher healthcare utilisation than pre-LC and contemporary non-COVID (all p < 0.0001). Healthcare utilisation of the LC group increased progressively between 2020 and 2023, compared with controls. Median cost per patient/year was also higher in individuals with LC than all control groups.
Conclusions
LC has been associated with substantial, persistent healthcare utilisation and cost over the last three years. Future funding, resources and staff for LC prevention, treatment and research must be prioritised to reduce sustained primary and secondary healthcare utilisation and costs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Health Informatics, University College London, London, UK.
- British Heart Foundation Data Science Centre, Health Data Research UK, London, UK.
- Cardiology, Barts Health NHS Trust, London, UK.
- School of Population Health and Environmental Sciences, King's College London, London, UK.
- National Institute for Health Research School for Primary Care Research, Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health, Manc…
- Keele Cardiovascular Research Group, Centre for Prognosis Research, Keele University, Keele, UK.
ORCID-Profile: Mehrdad A Mizani, Chris Tomlinson, Steffen Petersen, Amitava Banerjee
Förderung
- NHS England
- British Heart Foundation
- National Institute for Health and Care Research
Zitieren
APA
Mu, Y., Dashtban, A., Mizani, M. A., Tomlinson, C., Mohamed, M., Ashworth, M., Mamas, M., Priedon, R., Petersen, S., Kontopantelis, E., Horstmanshof, K., Pagel, C., Hocaoğlu, M., Khunti, K., Williams, R., Thygesen, J., Lorgelly, P., Gomes, M., Heightman, M., …, & CVD-COVID-UK/COVID-IMPACT Consortium (2024). Healthcare utilisation of 282,080 individuals with long COVID over two years: a multiple matched control, longitudinal cohort analysis. Journal of the Royal Society of Medicine. https://doi.org/10.1177/01410768241288345
Vancouver
Mu Y, Dashtban A, Mizani MA, Tomlinson C, Mohamed M, Ashworth M, et al. Healthcare utilisation of 282,080 individuals with long COVID over two years: a multiple matched control, longitudinal cohort analysis. Journal of the Royal Society of Medicine. 2024. doi:10.1177/01410768241288345
BibTeX
@article{Mu2024,
author = {Mu, Yi and Dashtban, Ashkan and Mizani, Mehrdad A and Tomlinson, Chris and Mohamed, Mohamed and Ashworth, Mark and Mamas, Mamas and Priedon, Rouven and Petersen, Steffen and Kontopantelis, Evan and Horstmanshof, Kim and Pagel, Christina and Hocaoğlu, Mevhibe and Khunti, Kamlesh and Williams, Richard and Thygesen, Johan and Lorgelly, Paula and Gomes, Manuel and Heightman, Melissa and Banerjee, Amitava and CVD-COVID-UK/COVID-IMPACT Consortium, CVD-COVID-UK/COVID-IMPACT Consortium},
title = {Healthcare utilisation of 282,080 individuals with long COVID over two years: a multiple matched control, longitudinal cohort analysis},
journal = {Journal of the Royal Society of Medicine},
year = {2024},
doi = {10.1177/01410768241288345}
}
EUVIMED